Who is sponsoring NCT05829811?

NCT05829811 is sponsored by Faculty Hospital AGEL Skalica.

What drugs are being tested in NCT05829811?

Interventions in NCT05829811: Lifestyle APP and Artificial Intelligence solutions validation.

What condition does NCT05829811 study?

NCT05829811 studies APP Elaborates Data Input From the Patient With Foot Ulcer.

Is NCT05829811 still recruiting?

NCT05829811 is currently not yet recruiting. Last updated 26 April 2023.

Last reviewed 2023-04-26 · How we verify

NCT05829811: MYFOOT-D

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tele-homecare Service for Diabetic Foot Patients (Risk 0, Risk 1 and Risk 2 Level): Testing and Validation of Dedicated APPs and Artificial Intelligence Solutions

Not yet recruiting Last updated 26 April 2023

What this trial tests

trial testing Lifestyle APP and Artificial Intelligence solutions validation in APP Elaborates Data Input From the Patient With Foot Ulcer in 100 participants. Not yet recruiting.

Timeline

1 September 2023

Primary endpoint
1 September 2025

1 September 2026

Quick facts

Lead sponsor	Faculty Hospital AGEL Skalica
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 September 2023
Primary completion	1 September 2025
Estimated completion	1 September 2026

Drugs / interventions tested

Lifestyle APP and Artificial Intelligence solutions validation

Conditions studied

APP Elaborates Data Input From the Patient With Foot Ulcer — all drugs for APP Elaborates Data Input From the Patient With Foot Ulcer →

Sponsor

Faculty Hospital AGEL Skalica

Who can join

Adults 18 to 80, any sex, with APP Elaborates Data Input From the Patient With Foot Ulcer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

MY FOOT project aims at filling the gap in mobile applications by providing evidence to both involved stakeholders, that is the remote assistance from the hospital and the patient, who is directly involved in their own care strategy. In particular, the application has to motivate patients and engage them in their self-care. Interaction with the mobile phone application is in the following terms: APP elaborates data input from the patient in terms of own feeling of health status, symptoms revealed along the day, events eventually occurred, photos of the foot, including ulcer zoom (if any), APP reports back about increase / decrease in the Risk Level graph through time, maps the ulcer evolution or healing based on photos elaboration, using adequate graphs reporting time in the main axis, whilst reminds personal goals to enact care on a regular basis on the basis of the current conditions, eventually alerts the patient to contact clinicians for a visual inspection at a hospital.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05829811 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Faculty Hospital AGEL Skalica
Last refreshed: 26 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05829811.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing